Human CD193/CCR3 HEK293T Stable Cell Line

Introduction

The Human CD193/CCR3 HEK293T Stable Cell Line is a valuable tool for studying the structure, activity, and application of the human chemokine receptor CD193, also known as CCR3. This stable cell line is derived from HEK293T cells, a commonly used cell line in biomedical research, and has been genetically modified to stably express the human CD193 protein. In this article, we will discuss the structure of CD193, its role in cell signaling, and its potential as a therapeutic target. We will also explore how the Human CD193/CCR3 HEK293T Stable Cell Line can be used in flow cytometry experiments to further our understanding of this important receptor.

Structure of CD193

CD193 is a G protein-coupled receptor (GPCR) that is primarily expressed on the surface of immune cells, including eosinophils, basophils, and Th2 cells. It is a member of the chemokine receptor family, which plays a critical role in regulating the migration and activation of immune cells. CD193 is composed of seven transmembrane domains and has a molecular weight of approximately 45 kDa. It has a high affinity for the chemokine eotaxin, which is involved in the recruitment of eosinophils to sites of inflammation.

Activity of CD193

CD193 is a key player in the immune response, particularly in the context of allergic inflammation. Upon binding to eotaxin, CD193 activates a signaling cascade that leads to the recruitment and activation of eosinophils. This process is essential for the clearance of parasitic infections, but in cases of chronic inflammation, it can also contribute to tissue damage and disease progression. In addition, CD193 has been implicated in the pathogenesis of asthma, allergic rhinitis, and other allergic diseases.

Therapeutic Target

Given its role in allergic inflammation, CD193 has emerged as a potential therapeutic target for the treatment of allergic diseases. By blocking the activity of CD193, it may be possible to reduce the recruitment and activation of eosinophils, thereby alleviating symptoms and preventing tissue damage. Several pharmaceutical companies are currently developing drugs that target CD193, and preclinical studies have shown promising results. The Human CD193/CCR3 HEK293T Stable Cell Line can be used to screen these potential drugs and further our understanding of CD193 as a therapeutic target.

Application in Flow Cytometry

The Human CD193/CCR3 HEK293T Stable Cell Line is a valuable tool for flow cytometry experiments aimed at studying CD193. This stable cell line expresses high levels of functional CD193, allowing for accurate and reproducible flow cytometry analysis. It can be used to validate the specificity of CD193-targeting drugs and to investigate the effects of these drugs on CD193 signaling. In addition, this cell line can be used to study the interaction between CD193 and other immune receptors, shedding light on the complex network of immune cell communication.

Conclusion

The Human CD193/CCR3 HEK293T Stable Cell Line is a powerful tool for studying the structure, activity, and application of CD193. It provides a reliable and consistent source of functional CD193, making it an ideal model for flow cytometry experiments. By using this stable cell line, researchers can gain a deeper understanding of the role of CD193 in immune responses and its potential as a therapeutic target for allergic diseases. As research on CD193 continues to advance, the Human CD193/CCR3 HEK293T Stable Cell Line will undoubtedly play a crucial role in furthering our understanding of this important receptor.